GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Paragon Care Ltd (ASX:PGC) » Definitions » Research & Development

Paragon Care (ASX:PGC) Research & Development : A$0 Mil (TTM As of Dec. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Paragon Care Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Paragon Care's Research & Development for the six months ended in Dec. 2024 was A$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was A$0 Mil.

Paragon Care Research & Development Historical Data

The historical data trend for Paragon Care's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paragon Care Research & Development Chart

Paragon Care Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Paragon Care Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Paragon Care Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Paragon Care  (ASX:PGC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Paragon Care Research & Development Related Terms

Thank you for viewing the detailed overview of Paragon Care's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Paragon Care Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Paragon Care Ltd (ASX:PGC) » Definitions » Research & Development
Comparable Companies
ASX:CYC MCK COR CAH ASX:SIG SHSE:601607 HSIC HKSE:01099 SHSE:600332 XSWX:GALE MIL:AMP NZSE:EBO TSE:7459 SHSE:600998 SHSE:600511 PDCO TSE:2784 TSE:9987 SHSE:600739 SHSE:600056
Traded in Other Exchanges
PXS:Germany
Address
77-97 Ricketts Road, Mount Waverley, Melbourne, VIC, AUS, 3149
Website
https://www.paragoncare.com.au
Paragon Care Ltd is a medical device company. The company provides medical equipment, devices, and consumables medical products to the healthcare market. The company provides solutions to various healthcare markets, aged care, and veterinary markets. The group is organized into two operating segments: ParagonCare and CH2 Holdings and the majority of its revenues are generated from the CH2 Holdings segment engaged in the distribution of pharmaceuticals, medical consumables, nutritional, and over-the-counter products to the healthcare market.